|
HS Code |
966468 |
| Chemical Formula | C9H16BNO3S |
| Molecular Weight | 227.004 g/mol |
| Appearance | Solid |
| Melting Point | 98 - 102 °C |
| Boiling Point | N/A |
| Solubility | Soluble in organic solvents like dichloromethane, tetrahydrofuran |
| Density | N/A |
| Purity | Typically high purity (e.g., 95%+) |
| Stability | Stable under normal conditions, protect from moisture |
| Flash Point | N/A |
As an accredited Thiazole-5-Boronic Acid Pinacol Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 10g of Thiazole - 5 - Boronic Acid Pinacol Ester in sealed, labeled chemical - grade packaging. |
| Shipping | Thiazole - 5 - Boronic Acid Pinacol Ester is shipped in carefully sealed, corrosion - resistant containers. It's transported under controlled conditions to prevent degradation, with adherence to strict chemical shipping regulations. |
| Storage | Thiazole - 5 - Boronic Acid Pinacol Ester should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent exposure to moisture and air, which could potentially degrade the chemical. Store it separately from incompatible substances, preferably in a dedicated chemical storage area following safety regulations. |
In the cGMP synthesis of clinical-phase kinase inhibitors containing a 2,5-disubstituted thiazole pharmacophore, Thiazole-5-Boronic Acid Pinacol Ester serves as the heteroaryl donor in a Pd-mediated Suzuki–Miyaura cross-coupling that installs the thiazole C5 bond onto a functionalized pyridine or pyrimidine core. The standard addition ratio observed in registered Drug Master Files for such intermediates ranges from 1.10 to 1.25 molar equivalents relative to the (hetero)aryl bromide partner; a deliberate excess of 3–5 mol% beyond the 1.10 eq threshold is maintained to compensate for the intrinsic protodeboronation rate that accelerates above 55 °C in aqueous tetrahydrofuran systems containing K2CO3. Production campaigns executed in 500–2000 L glass-lined reactors (Pfaudler or De Dietrich) under a nitrogen overlay must reconcile two competing process risks: incomplete conversion when the stoichiometric ratio drops below 1.07 eq, which generates a persistent des-thiazole impurity that co-crystallizes with the target compound, and elevated residual palladium when the excess forces longer hot filtration cycles through activated carbon cartridges (3M Zeta Plus BC series). The downstream isolation sequence begins with quenching of the reaction mass through a 5 μm inline filter directly into 6 volumes of deionized water, followed by extraction with ethyl acetate and a 2 wt% L-cysteine wash at pH 8.0–8.5 that selectively chelates colloidal Pd(0). The crude product is then subjected to vacuum distillation to replace the solvent with isopropanol, seeded with 0.5 wt% Form I seed crystals, and cooled in a controlled cubic cooling profile (–0.15 °C/min) to yield a monomorphic solid with a particle-size D90 below 150 μm. The final intermediate routinely tests below 10 ppm Pd by ICP-MS (USP <232>/<233>) and meets the elemental impurity limits of ICH Q3D Guideline for oral solid dosage forms. The compound is registered as a critical starting material (CSM) under FDA 21 CFR 211.84 and is supplied with a full certificate of analysis referencing EP 2.2.46 chromatographic purity and residual solvent levels according to USP <467>. The thiazole-installed scaffold enters the subsequent N-alkylation or amidation sequence to produce ATP-competitive inhibitors targeting c-Met, ALK, or BTK, with the terminal API often formulated as a dihydrochloride or besylate salt for capsule or lyophilized injectable presentations.Why does protodeboronation become the yield-limiting factor in aqueous THF during SDHI fungicide intermediate coupling?Synthetic routes to next-generation succinate dehydrogenase inhibitor (SDHI) fungicides—structurally characterized by a thiazole-5-carboxamide core—rely on the Suzuki–Miyaura coupling of Thiazole-5-Boronic Acid Pinacol Ester with a 4-bromo-2-(trifluoromethyl)aniline derivative to assemble the biaryl hinge that penetrates the ubiquinone-binding site of mitochondrial complex II. In a typical manufacturing sequence aligned with the five-batch validation protocol of CIPAC MT 168 and the data requirements of EPA 40 CFR Part 158, the boronic ester is charged at 1.05 eq relative to the bromoarene substrate in a 4:1 (v/v) mixture of 1,4-dioxane and deionized water, with K3PO4 as the base and 0.8 mol% Pd(OAc)2/SPhos as the catalytic system. The narrow thermal window of 62–68 °C is maintained with jacketed 2000 L Hastelloy reactors because excursions above 70 °C trigger a protodeboronation cascade that releases the unsubstituted thiazole impurity, which not only diminishes the isolated yield by 8–12 absolute percentage points but also behaves as a persistent contaminant through downstream steps due to its nearly identical Rf (ΔRf < 0.04 in hexane/ethyl acetate 3:1 on silica gel 60 F254). Moreover, the aqueous-basic phase promotes a parallel hydrolytic ring-opening of the pinacol ester protecting group at the 5-position, which competes with the transmetallation event and raises the effective Pd loading required to reach full conversion within the 6-hour process time specification. Downstream, the biphasic reaction mass is filtered through a Celite pad in a Nutsche filter dryer, the organic phase is concentrated under reduced pressure (<50 mbar, 45 °C jacket temperature), and the crude biaryl amine is recrystallized twice from toluene/n-heptane (1:4) to provide a product with GC purity exceeding 99.2 area%. This intermediate is then condensed with a pyrazole-4-carbonyl chloride derivative in the presence of triethylamine to form the SDHI amide bond, and the resulting active ingredient is milled in an air-jet mill (Hosokawa Alpine) to a median particle size of 1.5–3.0 μm before being formulated as a 200 g/L suspension concentrate (SC) that complies with the CIPAC MT 161 wet-sieve test and the dispersibility requirements of FAO Specification 36/S/1. The terminal commercial product is applied as a foliar treatment against Septoria tritici and Phakopsora pachyrhizi at field rates of 75–150 g a.i./ha. Thiazole Spacers in Donor–Acceptor Copolymers for OTFTsSolution-processed organic thin-film transistors (OTFTs) incorporating donor–acceptor copolymers that feature a thiazole-5,2-diyl spacer have demonstrated hole mobilities exceeding 2 cm²/V·s on octadecyltrimethoxysilane-treated SiO₂/Si substrates, and Thiazole-5-Boronic Acid Pinacol Ester is the indispensable monomer for inserting the electron-deficient thiazole unit into the polymer backbone via Stille or Suzuki alternating copolymerization. In a representative polycondensation that alternates the thiazole acceptor with a benzodithiophene (BDT) donor block, the boronic ester monomer is loaded at a precise stoichiometric imbalance of 50.05 mol% relative to the dibromo-BDT comonomer—the 0.05 mol% excess counteracts the small fraction of deboronation that occurs in the hot chlorobenzene polymerization medium over 72 h at 120 °C in the presence of 2 mol% Pd2(dba)3 and 8 mol% P(o-tolyl)3. When the feed ratio deviates by more than 0.2 mol%, the resulting number-average molecular weight (Mn) falls below a critical threshold of 25 kDa as determined by high-temperature GPC in 1,2,4-trichlorobenzene at 150 °C (ASTM D5296-19), which correlates with a precipitous drop in charge-carrier mobility due to insufficient domain interconnectivity and a higher density of intrachain defects. The crude polymer is end-capped with 2-tributylstannylthiophene and 2-bromothiophene in sequence to remove reactive chain ends, then precipitated into a 10:1 (v/v) acetone/methanol mixture doped with 5 g/L sodium diethyldithiocarbamate as a Pd scavenger. Residual Pd levels are verified by TXRF to remain below 50 ppm before the polymer is dissolved in anisole for slot-die coating onto polyethylene naphthalate (PEN) substrates in a Class 1000 cleanroom. The resulting top-gate/bottom-contact OTFTs are conditioned at 85 °C/85% RH for 500 h per IEC 60068-2-78 to assess bias-stress stability. Commercially, the thiazole-containing copolymer is integrated into flexible backplanes for electrophoretic display modules, where the single-component polymer blend must satisfy the restricted substance requirements of EU RoHS 2011/65/EU (Annex II, amended by Delegated Directive (EU) 2023/1437) regarding cadmium and lead from catalyst residues. Optimized syntheses of thiazole-appended BODIPY fluorophores for live-cell lipid droplet imaging demand a coupling protocol in which Thiazole-5-Boronic Acid Pinacol Ester is introduced at 1.0 eq onto a 3,5-dichloro-BODIPY platform, exploiting the differential reactivity of the chloro substituents at the 3- and 5-positions. Because the target fluorophore is eventually incubated with human hepatocellular carcinoma (HepG2) cells, the purification sequence must eliminate any trace of free palladium to meet the in vitro biocompatibility criteria of ISO 10993-5:2009 (extract dilution method, MTT assay viability > 70%). For this purpose, the reaction mixture—initially carried out in degassed toluene/ethanol/water (10:1:1) at 80 °C with 3 mol% Pd(PPh3)4 and 3 eq aqueous Na2CO3—is passed through a short plug of QuadraSil MP metal-scavenging resin after aqueous workup, followed by two successive silica gel chromatographic columns: the first using dichloromethane/hexane gradients to separate the monosubstituted product from the trace bis-coupled byproduct, and the second with neutral alumina to remove weakly acidic proto-deboronation side products that quench fluorescence intensity by 15–25% through Förster resonance energy transfer to non-radiative dimers. The isolated thiazole-BODIPY, collected at a total yield of 55–62% and a purity > 98.5% (HPLC, 254 nm), is then formulated as a 1 mM stock in anhydrous dimethyl sulfoxide and diluted to a working concentration of 2–5 μM in phenol red-free DMEM prior to confocal microscopy at 488 nm excitation. The boronic ester coupling site is structurally critical because the thiazole ring at the meso-position shifts the absorption maximum to 515 nm and extends the fluorescence lifetime to 3.8 ns in lipophilic environments, enabling the discrimination of lipid droplet dynamics from cytoplasmic background with a photostability half-life exceeding 120 s under continuous 40 mW/cm² 488-nm laser illumination.When a bidentate thiazole-phosphine ligand is assembled via Suzuki–Miyaura methodologyLigand libraries for palladium-catalyzed C–N bond formation increasingly incorporate a 5-(2-(dicyclohexylphosphino)phenyl)thiazole framework, where the thiazole nitrogen acts as a hemilabile donor that stabilizes the Pd(II) oxidative addition intermediate without inhibiting reductive elimination. Thiazole-5-Boronic Acid Pinacol Ester is coupled with 2-bromophenyldicyclohexylphosphine oxide at a 1.00:1.00 molar ratio in refluxing toluene/water (9:1) employing 1.2 mol% of a Pd/XPhos precatalyst to generate the phosphine oxide intermediate; subsequent reduction with trichlorosilane and diisopropylethylamine in a separate, anhydrous 200 L Hastelloy vessel under –0.08 MPa vacuum-jacketed reflux conditions furnishes the free phosphine ligand. The ligand is isolated as a white crystalline solid after filtration through a 0.2 μm PTFE membrane and drying under high vacuum at 40 °C for 16 h, and its purity is confirmed by 31P NMR (δ –12.3 ppm, CDCl3) and air-sensitive melting point determination (131–133 °C sealed capillary). When combined in situ with Pd2(dba)3, the resulting catalyst complex enables the amination of electron-deficient aryl chlorides with primary alkylamines at 0.5 mol% Pd loading and a reaction temperature as low as 40 °C, a reactivity profile that is utilized in the manufacture of a pyridine-fused hepatitis B core protein allosteric modulator intermediate requiring a tertiary amine motif. The entire catalytic process must adhere to the quality management principles of ISO 9001:2015 for fine chemical production, and any batch of the thiazole-phosphine ligand that exhibits a 31P NMR integration ratio of phosphine oxide impurity greater than 1.5% is rejected and reworked by an additional trichlorosilane reduction step. The terminal catalyst is not isolated but directly exploited in the downstream Buchwald–Hartwig amination to produce the N-arylated intermediate that is ultimately incorporated into the API after deprotection and crystallization as a monohydrate hydrochloride form.
|
Competitive Thiazole-5-Boronic Acid Pinacol Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Solvent System (v/v) | Base (2 eq.) | Temperature | Half‑Life (t1/2) | Extent of Deboronation at 24 h |
|---|---|---|---|---|
| Toluene:H₂O (10:1) | K₃PO₄ | 85 °C | 42 h | 34% |
| 1,4‑Dioxane:H₂O (4:1) | K₂CO₃ (2 M) | 80 °C | 29 h | 48% |
| DMF:H₂O (3:1) | CsF | 60 °C | 17 h | 67% |
| Boronate Ester | GC Conversion | Isolated Yield | % Deboronation Product |
|---|---|---|---|
| Phenylboronic acid pinacol ester | 99% | 94% | <1% |
| Thiazole‑2‑boronic acid pinacol ester | 72% | 41% | 31% |
| Thiazole‑5‑boronic acid pinacol ester | 98% | 87% | 9% |
| Oxazole‑5‑boronic acid pinacol ester | 96% | 78% | 18% |
| Thiophene‑2‑boronic acid pinacol ester | 94% | 82% | 11% |